197 related articles for article (PubMed ID: 37946710)
1. YAP Signaling Regulates the Cellular Uptake and Therapeutic Effect of Nanoparticles.
Cassani M; Fernandes S; Oliver-De La Cruz J; Durikova H; Vrbsky J; Patočka M; Hegrova V; Klimovic S; Pribyl J; Debellis D; Skladal P; Cavalieri F; Caruso F; Forte G
Adv Sci (Weinh); 2024 Jan; 11(2):e2302965. PubMed ID: 37946710
[TBL] [Abstract][Full Text] [Related]
2. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
3. Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Vici P; Ercolani C; Di Benedetto A; Pizzuti L; Di Lauro L; Sperati F; Terrenato I; Gamucci T; Natoli C; Di Filippo F; Botti C; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M
J Exp Clin Cancer Res; 2016 Apr; 35():62. PubMed ID: 27039292
[TBL] [Abstract][Full Text] [Related]
4. YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR‒AKT axis in patient-derived xenograft cells.
Parambil ST; Thankayyan SKR; Antony GR; Littleflower AB; Augustine P; Somanathan T; Subhadradevi L
Med Oncol; 2023 Apr; 40(5):137. PubMed ID: 37014473
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
6. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.
Zhang J; Ji JY; Yu M; Overholtzer M; Smolen GA; Wang R; Brugge JS; Dyson NJ; Haber DA
Nat Cell Biol; 2009 Dec; 11(12):1444-50. PubMed ID: 19935651
[TBL] [Abstract][Full Text] [Related]
7. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
8. Aurora A kinase activates YAP signaling in triple-negative breast cancer.
Chang SS; Yamaguchi H; Xia W; Lim SO; Khotskaya Y; Wu Y; Chang WC; Liu Q; Hung MC
Oncogene; 2017 Mar; 36(9):1265-1275. PubMed ID: 27593935
[TBL] [Abstract][Full Text] [Related]
9. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.
Marikawa Y; Alarcon VB
Mol Hum Reprod; 2019 Feb; 25(2):43-60. PubMed ID: 30395288
[TBL] [Abstract][Full Text] [Related]
10. GPER/Hippo-YAP signal is involved in Bisphenol S induced migration of triple negative breast cancer (TNBC) cells.
Deng Q; Jiang G; Wu Y; Li J; Liang W; Chen L; Su Q; Li W; Du J; Wong CKC; Chen Z; Wang H
J Hazard Mater; 2018 Aug; 355():1-9. PubMed ID: 29758456
[TBL] [Abstract][Full Text] [Related]
11. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.
Chen W; Bai Y; Patel C; Geng F
Biochem Biophys Res Commun; 2019 Dec; 520(2):263-268. PubMed ID: 31590917
[TBL] [Abstract][Full Text] [Related]
12. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.
Rigiracciolo DC; Nohata N; Lappano R; Cirillo F; Talia M; Scordamaglia D; Gutkind JS; Maggiolini M
Cells; 2020 Apr; 9(4):. PubMed ID: 32325700
[TBL] [Abstract][Full Text] [Related]
13. A role for Hippo/YAP-signaling in FGF-induced lens epithelial cell proliferation and fibre differentiation.
Dawes LJ; Shelley EJ; McAvoy JW; Lovicu FJ
Exp Eye Res; 2018 Apr; 169():122-133. PubMed ID: 29355736
[TBL] [Abstract][Full Text] [Related]
14. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
[TBL] [Abstract][Full Text] [Related]
15. KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling.
Yu B; Su J; Shi Q; Liu Q; Ma J; Ru G; Zhang L; Zhang J; Hu X; Tang J
Nat Commun; 2022 Apr; 13(1):2192. PubMed ID: 35449131
[TBL] [Abstract][Full Text] [Related]
16. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
[TBL] [Abstract][Full Text] [Related]
17. The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells.
Chan YT; Lin RJ; Wang YH; Hung TH; Huang Y; Yu J; Yu JC; Yu AL
Cell Commun Signal; 2023 Apr; 21(1):81. PubMed ID: 37081542
[TBL] [Abstract][Full Text] [Related]
18. Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC).
Rigiracciolo DC; Nohata N; Lappano R; Cirillo F; Talia M; Adame-Garcia SR; Arang N; Lubrano S; De Francesco EM; Belfiore A; Gutkind JS; Maggiolini M
J Exp Clin Cancer Res; 2022 Jun; 41(1):193. PubMed ID: 35655319
[TBL] [Abstract][Full Text] [Related]
19. YAP and the Hippo pathway in cholangiocarcinoma.
Sugihara T; Isomoto H; Gores G; Smoot R
J Gastroenterol; 2019 Jun; 54(6):485-491. PubMed ID: 30815737
[TBL] [Abstract][Full Text] [Related]
20. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
He L; Pratt H; Gao M; Wei F; Weng Z; Struhl K
Elife; 2021 Aug; 10():. PubMed ID: 34463254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
